Skip to main content
Signal8

Accustem Sciences Inc. (ACUT)

AccuStem Sciences, Inc. operates as a life science firm committed to improving the outlook for individuals battling cancer. Its primary innovation is the StemPrintER technology, an advanced multi-gene prognostic assay designed to predict the likelihood of recurrence for patients with Endocrine receptor-positive /HER2- breast cancer. The company also offers Spare, a related diagnostic tool that expands upon StemPrintER by incorporating two additional clinical markers. AccuStem Sciences, Inc. is based in New York, New York.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Accustem Sciences Inc. logo

Accustem Sciences Inc.

OTC:ACUTHealthcare
-9.23%$0.1180
Mkt Cap$1.9M
EV-
Float8.49M
O/S16.07M
VOL610 sh
$ Vol$74
RVOL0.22×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
Accustem Sciences Inc. logoOTC:ACUT$0.1180-9.23%
Short interest (FINRA)
0.0%
Oct 30 (18d)

Float 8.49M · Signal8 dilution snapshot · Aug 14, 2026

3.5K
Oct 30 (18d)prev 3.5K– 0.0%
1.00
Oct 30 (18d)prev 1.23▼ 18.7%
Borrow (IBKR)

The cost to borrow ACUT shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
50.0%
Oct 30 (18d)prev 39.0%▲ 11.0 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 20263.5K sh
Oct 15, 20263.5K sh
Sep 30, 20263.5K sh
Sep 15, 20263.9K sh
Aug 31, 20263.8K sh

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Oct 30
Latest sessions
DateReported short
Oct 30, 202650.0%
Oct 8, 202639.0%
Oct 7, 20260.1%
Oct 5, 202642.1%
Oct 2, 20267.7%
28-session median 24.0%mean 33.5%range 0.1–100.0%

130 calendar days requested; 29 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for ACUT: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 3,534 ACUT shares were sold short (0.04% of a 8.49M-share float, 1.00 days to cover).